Status:
NOT_YET_RECRUITING
Telomeres Length in Israeli Fibrotic ILD Patients
Lead Sponsor:
Barzilai Medical Center
Collaborating Sponsors:
Tel Aviv Medical Center
Israel Society of Pulmonology
Conditions:
Pulmonary Fibrosis
Eligibility:
All Genders
18+ years
Brief Summary
Individuals with fibrotic interstitial lung diseases (FILD) will be recruited after providing informed consent. in addition to routine data as usually collected in the clinic, blood samples will be ta...
Detailed Description
Scientific Background Interstitial lung diseases (ILD) comprise a large heterogenic group of conditions which involve the lung parenchyma by inflammation, fibrosis, or both. Fibrotic ILD (FILD), which...
Eligibility Criteria
Inclusion
- Adult subjects, aged ≥18-years-old
- Able and willing to provide informed consent to participate in the study
- Lung fibrosis evident on chest CT (signs of honeycombing and/or traction bronchiectasis) \[17\]
- Subjects fulfilling criteria 1 and 2 but with no evidence of chronic lung disease will serve as controls
Exclusion
- Subjects with sarcoidosis as the etiology for FILD
- Subjects who had undergone lung transplantation
- Pregnant women
Key Trial Info
Start Date :
April 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06885515
Start Date
April 1 2025
End Date
December 31 2027
Last Update
March 20 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.